Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1343538

registered interest
date	05/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus and Influenza: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether covid-19 booster vaccines and flu vaccines will be delivered (a) at the same time and (b) in pharmacies.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	27158
answer	answer is ministerial correction date of answer 13/07/2021 answer text <p>The Joint Committee on Vaccination and Immunisation (JCVI) published interim advice on a potential COVID-19 booster vaccination programme on 30 June, which is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/jcvi-interim-advice-on-a-potential-coronavirus-covid-19-booster-vaccine-programme-for-winter-2021-to-2022" target="_blank">https://www.gov.uk/government/publications/jcvi-interim-advice-on-a-potential-coronavirus-covid-19-booster-vaccine-programme-for-winter-2021-to-2022</a></p><p>The JCVI recommends a two staged approach is recommended, with those in the first stage offered a booster and flu vaccine as soon as possible from September. Those in the second stage would be offered a booster vaccine as soon as practicable after stage one, with equal emphasis on deployment of the flu vaccine where eligible.</p><p>Final decisions on the timing and scope of the vaccine booster programme, as well as cohorts and eligibility, will be made later in the year, informed by further independent advice from the JCVI. This includes further data on the durability of protection from vaccines, data supplied by manufacturers and clinical trial data regarding COVID-19 vaccine and flu vaccine coadministration. On 1 July, NHS England and NHS Improvement wrote to primary care providers, including community pharmacies, outlining the JCVI’s interim advice to allow local planning to begin.</p><p> </p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 13/07/2021 16:05:46 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4131 label Biography information for Jim Shannon

1331201

registered interest
date	09/06/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of who should be eligible to receive the Janssen covid-19 vaccine.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	13066
answer	answer is ministerial correction date of answer 18/06/2021 answer text <p>Deployment decisions for the Janssen vaccine within the COVID-19 vaccine programme are currently under consideration. The Department will be guided by the advice from the Joint Committee on Vaccination and Immunisation before making a final decision.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 18/06/2021 12:21:05 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4131 label Biography information for Jim Shannon

1327693

registered interest
date	25/05/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of using community development centres to help promote and administer the covid19 vaccine in areas where the take-up of the vaccine is lower than average.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	7178
answer	answer is ministerial correction date of answer 03/06/2021 answer text <p>The delivery of the vaccination programme is designed to be convenient and flexible, including in areas where there are groups with lower uptake. There is already a wide offer of vaccination settings such as religious and community centres. Local and national public health agencies are consulted on how best to utilise this flexibility to maximise uptake in groups with low vaccine uptake.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 03/06/2021 16:41:08 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4131 label Biography information for Jim Shannon

1314407

registered interest
date	13/05/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent estimate he has made of the level of protection given by each of the covid-19 vaccines available.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	1061
answer	answer is ministerial correction date of answer 21/05/2021 answer text <p>Public Health England publishes weekly COVID-19 vaccine surveillance reports which include the latest evidence on vaccine effectiveness against different outcomes, which is estimated by comparing rates of disease in vaccinated individuals to rates in unvaccinated individuals. The reports provide a summary of evidence on vaccine effectiveness against different outcomes for Pfizer/BioNTech and Oxford/AstraZeneca, including symptomatic disease, hospitalisation, mortality, infection and transmission. The latest report is available at the following link:</p><p><a href="https://eur01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.gov.uk%2Fgovernment%2Fpublications%2Fcovid-19-vaccine-surveillance-report&amp;data=04%7C01%7Ccovid19surv%40phe.gov.uk%7Cb2598e32058644d021bf08d916c0fea2%7Cee4e14994a354b2ead475f3cf9de8666%7C0%7C0%7C637565840415583246%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&amp;sdata=MFmH8qQxqsBUGSNXnO5e7tyCyPWBtYpuq%2FF3GUfu6AI%3D&amp;reserved=0" target="_blank">https://www.gov.uk/government/publications/covid-19-vaccine-surveillance-report</a></p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 21/05/2021 12:17:54 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4131 label Biography information for Jim Shannon

1308454

registered interest
date	13/04/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether certain variants of covid-19 are less susceptible to vaccines.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	180499
answer	answer is ministerial correction date of answer 20/04/2021 answer text <p>All currently deployed COVID-19 vaccines in the United Kingdom are effective against the prevalent strains in the country.</p><p>Public Health England has published early estimates of vaccine effectiveness which includes the United Kingdom variant of concern VOC202012/01 and has shown no substantial change in vaccine effectiveness against this variant, which is now the dominant strain of COVID-19 in the UK. If other emerging variants do reduce vaccine efficacy, it would still be anticipated that the vaccines currently in deployment would continue to provide protection to some extent.</p><p>The Government are already taking several steps to understand the efficacy of the current UK vaccine portfolio against new and emerging virus variants. This includes a partnership with CureVac to develop a variation of an existing vaccine tailored to the most appropriate variant target.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 20/04/2021 15:31:12 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4131 label Biography information for Jim Shannon

1306217

registered interest
date	25/03/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether he has plans to prioritise elite level athletes for early covid-19 vaccinations in light of the progress of the vaccination programme.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	175850
answer	answer is ministerial correction date of answer 13/04/2021 answer text <p>If elite level athletes are captured in phase one or two of the programme due to age or clinical need, then they will be vaccinated accordingly. However, we are not currently planning to prioritise elite level athletes for COVID-19 vaccination.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 13/04/2021 09:03:14 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4131 label Biography information for Jim Shannon

1304063

registered interest
date	18/03/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Screening and Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of vaccinating secondary pupils against covid-19; and whether tests on children aged over 11 have been undertaken on the safety of the covid-19 vaccine for that age group.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	171605
answer	answer is ministerial correction date of answer 25/03/2021 answer text <p>At present, there is very limited data on vaccination in adolescents with no data on vaccination in younger children. The Joint Commission on Vaccination and Immunisation advises that only those children at very high risk of exposure and serious outcomes, such as older children with severe neuro-disabilities that require residential care, should be offered vaccination as part of phase one. The Green Book also sets out that children under 16 years of age, even if they are clinically extremely vulnerable, are at low risk of serious morbidity and mortality and given the absence of safety and efficacy data on the vaccine, are not recommended for vaccination. Vaccine trials including on those under 18 years old are the responsibility of vaccine developers. We are aware of a number of planned COVID-19 vaccine trials in children and will monitor the results closely.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 25/03/2021 15:17:19 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4131 label Biography information for Jim Shannon

1303281

registered interest
date	17/03/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that GPs are able to identify (a) asthma and (b) ME patients for the covid-19 vaccine through their medical records.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	170640
answer	answer is ministerial correction date of answer 08/04/2021 answer text <p>To assist general practitioners (GPs) identify patients eligible for a vaccine in each priority cohort, NHS Digital has aligned specifications for the identification of patients via their medical records with GP system suppliers. Asthma sufferers will be identified through this system and invited to make an appointment when the vaccination programme has reached their respective priority cohort.</p><p> </p><p>To date, chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) has not been identified as either a condition that makes an individual clinically extremely vulnerable or as a condition that would place an individual at increased clinical risk from COVID-19. GPs will therefore not specifically be identifying CFS/ME patients for COVID-19 vaccines via their medical records. It is more likely that patients with CFS/ME will be offered COVID-19 vaccines because they are eligible through other means such as their age, or they have other underlying health issues that would put them at increased clinical risk.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 08/04/2021 09:02:10 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4131 label Biography information for Jim Shannon

1293264

registered interest
date	01/03/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans his Department has to monitor the effectiveness of existing covid-19 vaccines against new variants of the SARS-CoV-2 virus.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	160666
answer	answer is ministerial correction date of answer 23/03/2021 answer text <p>Public Health England has published early estimates of vaccine effectiveness which includes the United Kingdom variant of concern VOC202012/01, which is available at the following link:</p><p> </p><p><a href="https://www.medrxiv.org/content/10.1101/2021.03.01.21252652v1" target="_blank">https://www.medrxiv.org/content/10.1101/2021.03.01.21252652v1</a></p><p> </p><p>The 2021 Budget provided an extra £1.65 billion for the COVID-19 vaccination programme. This included £28 million to increase the UK’s capacity for vaccine testing, support for clinical trials and improve the ability to rapidly acquire samples of new variants of COVID-19 and £22 million for a world-leading study to test the effectiveness of combinations of different vaccines. This will also fund the world’s first study assessing the effectiveness of a third dose of vaccine to improve the response against current and future variants of COVID-19. A further £5 million investment in clinical-scale mRNA manufacturing has been allocated to create a ‘library’ of vaccines that will work against COVID-19 variants for possible rapid response deployment.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 23/03/2021 10:58:08 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4131 label Biography information for Jim Shannon

1293265

registered interest
date	01/03/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans his Department has to monitor the effectiveness of different covid-19 vaccines in different age groups.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	160667
answer	answer is ministerial correction date of answer 23/03/2021 answer text <p>Public Health England (PHE) is monitoring vaccine effectiveness in all eligible groups.</p><p> </p><p>PHE has published an assessment on vaccine effectiveness in adults aged 70 years and older and in healthcare workers, which is available at the following link:</p><p> </p><p><a href="https://www.medrxiv.org/content/10.1101/2021.03.01.21252652v1" target="_blank">https://www.medrxiv.org/content/10.1101/2021.03.01.21252652v1</a></p><p> </p><p>As the COVID-19 vaccination programme continues in younger age groups, vaccine effectiveness estimates in these age groups will be published.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 23/03/2021 10:54:15 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4131 label Biography information for Jim Shannon